Vancomycin: all 177 studies that test it

Page 2 of 2. Open to participants first (43), then studies with results posted, then the rest; newest registration first within each.

• Topical Antibiotics in Surgical SiteCompletedNCT05363462Not applicable
• Oral Vancomycin Vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's InfectionCompletedNCT05320068Phase 3
• Efficacy of Diluted Betadine vs Antibiotic Installation Before Surgical Wound Closure in Prevention of Post Cardiac Surgery Wound InfectionStatus unknownNCT05276687Phase 4
• Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)TerminatedNCT04968951Early Phase 1
• Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile NeutropeniaCompletedNCT04948463Phase 4
• To Assess Use of Vancomycin Powder in Craniotomy on Wound Infection RatesStatus unknownNCT04917627Phase 4
• Effect of Vancomycin After Catheter ReplacementStatus unknownNCT04856878Phase 4
• Antibiotics Continuous Infusion at HomeStatus unknownNCT04816968Phase 1
• Local Antibiotics for Breast ImplantsActive, not recruitingNCT04731025Phase 3
• Vancomycin Tissue Concentrations by Bier Block or Intravenous AdministrationCompletedNCT04673877Phase 1
• Topical Vancomycin Over Sternal Edge in Cardiac SurgeryCompletedNCT04500275Phase 4
• Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized PatientsWithdrawnNCT04246151Early Phase 1
• Prospective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDIWithdrawnNCT04241744Phase 4
• First-in-human Study of VE303 in Healthy Adult VolunteersCompletedNCT04236778Phase 1
• MTT for Children With ASD Who Have Gastrointestinal DisordersActive, not recruitingNCT04182633Phase 2
• Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile InfectionCompletedNCT04138706Phase 3
• Vancomycin Dosage Strategy Based on a Trough Concentration ModelCompletedNCT04088305Phase 4
• Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) OralWithdrawnNCT04025567Phase 2
• Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal FusionCompletedNCT04017468Phase 2
• Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)TerminatedNCT04000555Phase 4
• The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart SurgeryStatus unknownNCT03939273Not applicable
• Evaluating the Efficacy and Safety of Intra-wound Vancomycin Powder in High Risk PatientsActive, not recruitingNCT03839914Not applicable
• Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. DifficileCompletedNCT03827447Phase 1
• Vancomycin, Gentamycin in Infective EndocarditisStatus unknownNCT03688659Not applicable
• Vancomycin in the Target Site Treatment of Intracranial InfectionStatus unknownNCT03585426Phase 4
• The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After CraniotomyStatus unknownNCT03466645Phase 1/2
• Oral Vancomycin to Prevent Recurrent C Difficile Infection With AntibioticsCompletedNCT03466502Phase 4
• Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal DisordersStatus unknownNCT03408886Phase 2
• Evaluate the Effects of the Environmental Change in Intestine by Antibiotics on the Pharmacokinetic Characteristics of Simvastatin in Healthy Male VolunteersCompletedNCT03403972Phase 1
• Prevention of Infections in Cardiac Surgery (PICS) Prevena StudyCompletedNCT03402945Phase 4
• Study for Antibiotic Impregnated Calcium Sulfate Beads as Prophylaxis for Surgical Site InfectionStatus unknownNCT03308253Phase 4
• Effect of Antibiotics on Gut Microbiome and Plasma MetabolomeCompletedNCT03273296Phase 4
• Intrawound Vancomycin Prophylaxis for Neural StimulatorStatus unknownNCT03221023Phase 2/3
• Oral Vancomycin for Preventing Clostridium Difficile RecurrenceTerminatedNCT03200093Phase 4
• Vancomycin Treatment in Recurrent PSC in Liver Transplant PatientsWithdrawnNCT03046901Not applicable
• Neonatal Vancomycin TrialTerminatedNCT02790996Phase 2
• Safety and TDM of Continuous Infusion Vancomycin Through Continuous Renal Replacement Therapy SolutionStatus unknownNCT02663596Phase 1
• Intrawound Vancomycin Powder in Spinal Fusion SurgeryCompletedNCT02631408Phase 4
• Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis PatientsStatus unknownNCT02605213Phase 4
• Intracameral Antibiotic Safety StudySuspendedNCT02590523Phase 3
• Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSACompletedNCT02582203Phase 4
• A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing CholangitisCompletedNCT02464020Phase 1
• Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile NeutropeniaStatus unknownNCT02463747Phase 4
• Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of VancomycinStatus unknownNCT02443064Phase 4
• Local Application of Vancomycin Powder in Grade I-IIIA Open FracturesTerminatedNCT02400112Phase 4
• The Role of the Microbiota in the Systemic Immune ResponseCompletedNCT02340182Not applicable
• Surgical Infection Rates With Adjunct Vancomycin Compared to Standard Peri-Operative IV AntibioticsStatus unknownNCT02299882Not applicable
• Prevention of Infections in Cardiac SurgeryTerminatedNCT02285140Not applicable
• A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older PopulationCompletedNCT02254967Phase 4
• The Importance of the Gut Microbiota in Body Weight Control and Insulin SensitivityCompletedNCT02241421Not applicable
• Vancomycin Prophylaxis in Recurrent Clostridium Difficile InfectionStatus unknownNCT02237859Phase 4
• The Role of the Gut Microbiota in the Systemic Immune Response During Human EndotoxemiaCompletedNCT02127749Not applicable
• Prevention of Infection in Closed Fractures: Cefazolin Versus VancomycinTerminatedNCT02027532Not applicable
• Vancomycin in Spine SurgeryStatus unknownNCT01977989Phase 4
• Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical VentilationCompletedNCT01925066Phase 2
• Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA ScreeningCompletedNCT01918813Not applicable
• Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in CirrhosisStatus unknownNCT01820026Phase 4
• Staphylococcus Aureus Bacteremia Antibiotic Treatment OptionsCompletedNCT01792804Phase 3
• Eradication of Gut MicrobiotaCompletedNCT01633762Early Phase 1
• The Effects of Daptomycin and Cytokines Production in Comparison With VancomycinCompletedNCT01626560Phase 4
• Effectiveness of Vancomycin Loading TherapyCompletedNCT01623817Not applicable
• Comparative Effectiveness and Cost-Benefit Analysis of Vancomycin Powder in High Risk Spine Surgery PatientsWithdrawnNCT01566422Not applicable
• Pharmacokinetics of Vancomycin for Inhalation in Cystic FibrosisWithdrawnNCT01509339Phase 1
• Efficacy of Local Powder ProphylacticsStatus unknownNCT01372371Not applicable
• Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based RegimensTerminatedNCT01133600Phase 4
• Study of Antibiotics in Cerebrospinal Fluid Following Intravenous InjectionWithdrawnNCT00925093Phase 1
• The Use of Antimicrobial Agents in the Inhibition of Mutans Streptococci in Children With Dental CariesCompletedNCT00612469Not applicable
• Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus AureusCompletedNCT00572559Phase 4
• Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic PatientsCompletedNCT00454272Phase 4
• Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA InfectionCompletedNCT00304811Phase 4
• Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or ErysipelasCompletedNCT00295178Phase 4
• Pharmacokinetics of Vancomycin in Adults Receiving ECMOCompletedNCT00281281Phase 4
• Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative StaphylococcusCompletedNCT00175370Not applicable
• Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.Status unknownNCT00150852Phase 2
• Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive BacteriaCompletedNCT00037050Phase 3
• Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive InfectionCompletedNCT00035425Phase 3
• Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountCompletedNCT00003805Phase 3

← Vancomycin overview